Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-02-08 @ 8:36 AM
Study NCT ID:
NCT02409667
Status:
COMPLETED
Last Update Posted:
2019-05-13
First Post:
2015-03-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Plaque Psoriasis Efficacy and Safety With Secukinumab
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-31
First Submit QC Date:
None
Study First Post Date:
2015-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-04
Results First Submit QC Date:
None
Results First Post Date:
2019-05-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-12
Last Update Post Date:
2019-05-13
Last Update Post Date Type:
ACTUAL